Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Siamak Daneshmand, MD, Keck School of Medicine, Los Angeles, CA, discusses the treatment of stage II seminomas, which are currently treated using radiotherapy or chemotherapy, and outlines the potential role of surgery and micro-RNA in the treatment of seminomas in the future. This interview took place during the 2021 Genitourinary Cancers Symposium.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.